Screening inventories to detect depression in chronic hepatitis C patients

General Hospital Psychiatry

Volumn 34, Issue 1, 2012, Pages 40-45

  Fábregas, Bruno Cópio ^a   Vitorino, Flávia Domingues ^a   Rocha, Débora Millard ^a   Moura, Alexandre Sampaio ^a   Carmo, Ricardo Andrade ^a   Teixeira, AntÔnio Lúcio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chronic hepatitis C; Depression; Diagnosis; Interferon ; Screening

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ASSESSMENT; CONTROLLED STUDY; CRONBACH ALPHA COEFFICIENT; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREDICTIVE VALUE; PSYCHOLOGIC TEST; PSYCHOMETRY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADULT; BRAZIL; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MASS SCREENING; MEDICAL AUDIT; MIDDLE AGED;

EID: 84855357962     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2011.09.002     Document Type: Article

References (31)

1. World Health Organization Hepatitis C - global prevalence (update). Wkly Epidemiol Rec 2000, 75(3):18-19.
2. Di Bisceglie A.M. Hepatitis C and hepatocellular carcinoma. Hepatology 1997, 26(3 Suppl 1):34S-38S.
3. Kim W.R. The burden of hepatitis C in the United States. Hepatology 2002, 36(5 Suppl 1):S30-34.
4. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales F.L., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002, 347(13):975-982.
5. Poordad F., Khungar V. Emerging therapeutic options in hepatitis c virus infection. Am J Manag Care 2011, 17(4 Suppl):S123-S130.
6. Batista-Neves S.C., Quarantini L.C., de Almeida A.G., Bressan R.A., Lacerda A.L., de-Oliveira I.R., et al. High frequency of unrecognized mental disorders in HCV-infected patients. Gen Hosp Psychiatry 2008, 30(1):80-82.
7. Dieperink E., Willenbring M., Ho S.B. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. Am J Psychiatry 2000, 157(6):867-876.
8. Fabregas B.C., Moura A.S., Marciano R.C., Carmo R.A., Teixeira A.L. Clinical management of a patient with drug dependence who attempted suicide while receiving peginterferon therapy for chronic hepatitis C. Braz J Infect Dis 2009, 13(5):387-390.
9. NIH consensus statement on management of hepatitis C: 2002. NIH Consens State Sci Statements 2002, 19(3):1-46.
10. Williams J.W., Pignone M., Ramirez G., Perez Stellato C. Identifying depression in primary care: a literature synthesis of case-finding instruments. Gen Hosp Psychiatry 2002, 24(4):225-237.
11. Golden J., Conroy R.M., O'Dwyer A.M. Reliability and validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory (Full and FastScreen scales) in detecting depression in persons with hepatitis C. J Affect Disord 2007, 100(1-3):265-269.
12. Holtzheimer P.E., Veitengruber J., Wang C.C., Krows M., Thiede H., Wald A., et al. Utility of the Beck Depression Inventory to screen for and track depression in injection drug users seeking hepatitis C treatment. Gen Hosp Psychiatry 2010, 32(4):426-432.
13. Brown-DeGagne A.M., McGlone J., Santor D.A. Somatic complaints disproportionately contribute to Beck Depression Inventory estimates of depression severity in individuals with multiple chemical sensitivity. J Occup Environ Med 1998, 40(10):862-869.
14. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl 20):22-33. [quiz 4-57].
15. Botega N.J., Bio M.R., Zomignani M.A., Garcia C., Pereira W.A. Mood disorders among inpatients in ambulatory and validation of the anxiety and depression scale HAD. Rev Saude Publica 1995, 29(5):355-363.
16. Gorenstein C., Andrade L. Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects. Braz J Med Biol Res 1996, 29(4):453-457.
17. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961 Jun, 4:561-571.
18. Loftis J.M., Socherman R.E., Howell C.D., Whitehead A.J., Hill J.A., Dominitz J.A., et al. Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C. Neurosci Lett 2004, 365(2):87-91.
19. Beck A.T., Guth D., Steer R.A., Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 1997, 35(8):785-791.
20. Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983, 67(6):361-370.
21. Kraus M.R., Schafer A., Faller H., Csef H., Scheurlen M. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J Clin Psychiatry 2003, 64(6):708-714.
22. Kraus M.R., Schafer A., Schottker K., Keicher C., Weissbrich B., Hofbauer I., et al. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. Gut 2008, 57(4):531-536.
23. Lee D.H., Jamal H., Regenstein F.G., Perrillo R.P. Morbidity of chronic hepatitis C as seen in a tertiary care medical center. Dig Dis Sci 1997, 42(1):186-191.
24. Fireman M., Indest D.W., Blackwell A., Whitehead A.J., Hauser P. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care. Clin Infect Dis 2005, 40(Suppl 5):S286-S291.
25. Van Gool A.R., Kruit W.H., Engels F.K., Stoter G., Bannink M., Eggermont A.M. Neuropsychiatric side effects of interferon-alfa therapy. Pharm World Sci 2003, 25(1):11-20.
26. Raison C.L., Broadwell S.D., Borisov A.S., Manatunga A.K., Capuron L., Woolwine B.J., et al. Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Brain Behav Immun 2005, 19(1):23-27.
27. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33(1):159-174.
28. Cicchetti D.V. Guidelines, criteria and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 1994, 6:284-290.
29. Patterson A.L., Morasco B.J., Fuller B.E., Indest D.W., Loftis J.M., Hauser P. Screening for depression in patients with hepatitis C using the Beck Depression Inventory-II: do somatic symptoms compromise validity?. Gen Hosp Psychiatry 2011, 33(4):354-362.
30. Dieperink E., Ho S.B., Thuras P., Willenbring M.L. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics 2003, 44(2):104-112.
31. Golden J., O'Dwyer A.M., Conroy R.M. Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Gen Hosp Psychiatry 2005, 27(6):431-438.